Evaluation of cardioprotection and bio-efficacy enhancement of stevioside and diltiazem in rats
Abstract Background Cardiovascular diseases and resultant complications of cardio-therapeutic regimens are one of the leading causes of mortalities in developing countries. Diltiazem is a calcium channel blocker primarily used in treatment of supraventricular arrhythmias, systemic hypertension, and...
Main Authors: | Laxit Bhatt, Jay Amrutia, Manodeep Chakraborty, Jagadish Kamath |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-07-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43094-020-00054-w |
Similar Items
-
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
by: Gerd Heusch, et al.
Published: (2023-11-01) -
Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition
by: Hansen J, et al.
Published: (2020-07-01) -
DJ-1 administration exerts cardioprotection in a mouse model of acute myocardial infarction
by: Alex Gallinat, et al.
Published: (2022-09-01) -
Targeting the Endothelium to Achieve Cardioprotection
by: Nicolas Herrera-Zelada, et al.
Published: (2021-02-01) -
Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
by: M. G Bubnova
Published: (2013-03-01)